beauvericin has been researched along with Bile Duct Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Celli, A; Gores, GJ; Harnois, DM; LaRusso, NF; Que, FG | 1 |
1 other study(ies) available for beauvericin and Bile Duct Cancer
| Article | Year |
|---|---|
Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line.
Topics: Anti-Bacterial Agents; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Depsipeptides; Humans; Oligonucleotides, Antisense; Peptides; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 1997 |